Tag: Diabetes: Type I

Enhanced automatic insulin delivery system cleared for people with type 1 diabetes ≥6 years

Findings persist even after controlling for adverse neighborhood conditions

Greater increases seen in incidence of both types for those from racial and ethnic-minority groups such as non-Hispanic Blacks, Hispanics

Greater percentage of time with glucose level in target range seen for young children using closed-loop system

Stimulated C-peptide secretion partially preserved with verapamil versus placebo at 52 weeks after diagnosis of type 1 diabetes

Significant reductions seen in weight, HbA1c, total daily dose of insulin with GLP-1RA, and in HbA1c and basal insulin with SGLTi

Significant positive association seen after adjustment for age, sex, employment status, BMI, diabetes duration, insulin secretion

Lower odds ratios seen for insulin pump use for Hispanic, Black, other race versus White; with lower education, lower household income

Children in most optimal HbA1c quintile had substantially better educational attainment, while those in least optimal quintile had worse attainment

Improvements seen in blood pressure and central and peripheral aortic stiffness and pressure hemodynamics in teens with type 1 diabetes